Khalili-Shirazi A, Atkinson P, Gregson N, Hughes R A
Department of Neurology, UMDS, London, UK.
J Neuroimmunol. 1993 Jul;46(1-2):245-51. doi: 10.1016/0165-5728(93)90255-w.
Immunisation with the peripheral nerve myelin proteins P0 or P2 induces inflammatory neuropathy in animals. We sought antibodies with an ELISA to these proteins in 38 patients with acute Guillain-Barré syndrome (GBS), 32 patients with chronic idiopathic demyelinating polyradiculoneuropathy (CIDP), 31 patients with other neuropathies (ONP) and 26 normal control (NC) subjects. We discovered IgM antibodies to human P0 protein in the sera of 18.5% of the patients with GBS, 15.6% with CIDP, 6.4% with ONP and 3.8% of NC subjects. Of the sera which reacted with P0, sera from 4/7 of GBS, 3/5 of CIDP, 1/2 of ONP patients and 0/1 of NC subjects reacted with a synthetic P0 peptide representing residues 150-169 from the cytoplasmic portion of the molecule. IgG antibodies to P0 were slightly less common than IgM antibodies, being present in only 7.9% of GBS, 0% of CIDP and 3% of ONP patients and 0% of NC subjects. We found antibodies to bovine P2 protein more commonly than antibodies to P0. IgM antibodies were present in 39.5% of GBS, 34.4% of CIDP, 16.1% of ONP patients and 15.4% of NC subjects. IgG antibodies were present in 18.4% of GBS, 12.5% of CIDP, 3.2% of ONP patients and 7.6% of NCs. Of the sera which contained antibodies to P2 protein, only a few reacted with P2 peptides 14-25 or 58-81, but without any consistent pattern of reactivity.(ABSTRACT TRUNCATED AT 250 WORDS)
用周围神经髓磷脂蛋白P0或P2进行免疫会在动物中诱发炎性神经病变。我们用酶联免疫吸附测定法(ELISA)检测了38例急性吉兰 - 巴雷综合征(GBS)患者、32例慢性特发性脱髓鞘性多发性神经根神经病(CIDP)患者、31例其他神经病(ONP)患者和26名正常对照(NC)受试者血清中针对这些蛋白的抗体。我们在18.5%的GBS患者、15.6%的CIDP患者、6.4%的ONP患者和3.8%的NC受试者血清中发现了针对人P0蛋白的IgM抗体。在与P0发生反应的血清中,GBS患者的4/7、CIDP患者的3/5、ONP患者的1/2以及NC受试者的0/1血清与代表该分子胞质部分150 - 169位残基的合成P0肽发生反应。针对P0的IgG抗体比IgM抗体稍少见,仅存在于7.9%的GBS患者、0%的CIDP患者、3%的ONP患者和0%的NC受试者中。我们发现针对牛P2蛋白的抗体比针对P0的抗体更常见。IgM抗体存在于39.5%的GBS患者、34.4%的CIDP患者、16.1%的ONP患者和15.4%的NC受试者中。IgG抗体存在于18.4%的GBS患者、12.5%的CIDP患者、3.2%的ONP患者和7.6%的NC受试者中。在含有针对P2蛋白抗体的血清中,只有少数与P2肽14 - 25或58 - 81发生反应,但没有任何一致的反应模式。(摘要截短于250字)